SEC Fines MusclePharm For Unreported Executive Perks, Disclosure Gaps
This article was originally published in The Tan Sheet
The firm, which recently appointed a board chairman as founder and CEO Brad Pyatt moved out of the post in a restructuring, agrees to a $700,000 fine and to make management changes including hiring an independent monitor for one year.
You may also be interested in...
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.